The House Energy and Commerce Committee held a full committee markup this week of H.R. 5651, "The Food and Drug Administration Reform Act of 2012," which consists of all the user fee proposals.
Mark Leahey, President and CEO of MDMA, thanked the leaders of the Committee for having an open and transparent process to improve the user fee programs, noting that patient care is improved when medical device innovators develop new technologies under the assurance of a fair,...















